Use of 'eradication' in HIV cure-related research: a public health debate.

Publisher: BioMed Central Country of Publication: England NLM ID: 100968562 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2458 (Electronic) Linking ISSN: 14712458 NLM ISO Abbreviation: BMC Public Health Subsets: MEDLINE

Original Publication: London : BioMed Central, [2001-

Biomedical Research* ; Terminology as Topic*; HIV Infections/*prevention & control; Disease Eradication ; Humans ; Public Health

Background: The landscape of Human Immunodeficiency Virus (HIV) research has changed drastically over the past three decades. With the remarkable success of antiretroviral treatment (ART) in decreasing AIDS-related mortality, some researchers have shifted their HIV research focus from treatment to cure research. The HIV cure research community often uses the term eradication to describe the science, and talks about eradicating the virus from the body. In public discourse, the term eradication could be conflated with disease eradication at the population level. In this paper, we call for a reframing of HIV cure research as control, as it is a more accurate descriptor and achievable goal in the foreseeable future.
Discussion: The properties of HIV are discordant with eradicability standards at both the individual level (as a clinical concept), and at the population level (as a public health concept). At the individual level, true eradication would necessitate absolute elimination of all latent HIV reservoirs from the body. Current HIV cure-related research strategies have proven unsuccessful at accurately quantifying, let alone eliminating these reservoirs. At the population level, eradication implies the permanent global reduction of HIV to zero new cases and to zero risk for future cases. Given the absence of an efficacious HIV vaccine and the impracticality and unethicality of eliminating animal reservoirs, global eradication of HIV is highly implausible. From a public health perspective, HIV eradication remains an elusive goal.
Conclusion: The term 'eradication' is a misleading description of current HIV cure-related research. Instead, we call for the use of more realistic expressions such as 'sustained virologic HIV suppression (or control)' or 'management of HIV persistence' to describe HIV cure-related research. Using these terms reorients what HIV cure science can potentially achieve in the near future and avoids creating unrealistic expectations, particularly among the millions of people globally who live with HIV.

Annu Rev Med. 2016;67:215-28. (PMID: 26526767)
AIDS Res Hum Retroviruses. 2015 Jan;31(1):13-24. (PMID: 25385703)
AIDS Res Hum Retroviruses. 2011 Apr;27(4):347-53. (PMID: 21314240)
PLoS Pathog. 2013;9(5):e1003347. (PMID: 23671416)
PLoS Med. 2017 Apr 4;14(4):e1002253. (PMID: 28376085)
Philos Trans R Soc Lond B Biol Sci. 2017 May 26;372(1721):. (PMID: 28396469)
Science. 1997 Nov 14;278(5341):1295-300. (PMID: 9360927)
Immunol Rev. 2013 Jul;254(1):355-71. (PMID: 23772631)
Cell. 2013 Oct 24;155(3):540-51. (PMID: 24243014)
AIDS. 2010 Nov 27;24(18):2803-8. (PMID: 20962613)
J Acquir Immune Defic Syndr. 2016 Sep 1;73(1):39-46. (PMID: 27028501)
N Engl J Med. 2014 Dec 18;371(25):2437-8. (PMID: 25517721)
N Engl J Med. 2014 Mar 6;370(10):901-10. (PMID: 24597865)
J Acquir Immune Defic Syndr. 2014 Nov 1;67(3):e110-1. (PMID: 25314254)
Curr Opin HIV AIDS. 2015 Jan;10(1):18-28. (PMID: 25415421)
N Engl J Med. 2015 Feb 19;372(8):786-8. (PMID: 25693029)
Proc Natl Acad Sci U S A. 1997 Nov 25;94(24):13193-7. (PMID: 9371822)
Nat Rev Microbiol. 2014 Nov;12(11):750-64. (PMID: 25402363)
Blood. 2011 Mar 10;117(10):2791-9. (PMID: 21148083)
Trends Microbiol. 2014 Oct;22(10):547-9. (PMID: 25280965)
N Engl J Med. 2013 Nov 7;369(19):1828-35. (PMID: 24152233)
Sci Rep. 2016 Feb 24;6:22183. (PMID: 26908162)
Bull World Health Organ. 1998;76 Suppl 2:17-21. (PMID: 10063668)
PLoS One. 2012;7(3):e33948. (PMID: 22479485)
Trends Mol Med. 2016 Jan;22(1):10-27. (PMID: 26691297)
Nat Rev Microbiol. 2016 Jan;14(1):55-60. (PMID: 26616417)
BMC Med Ethics. 2015 Mar 27;16:18. (PMID: 25885856)
MMWR Recomm Rep. 1993 Dec 31;42(RR-16):1-38. (PMID: 8145708)
Front Immunol. 2013 Oct 18;4:337. (PMID: 24151495)
PLoS Pathog. 2016 Apr 27;12(4):e1005535. (PMID: 27119536)
Curr HIV/AIDS Rep. 2016 Feb;13(1):31-7. (PMID: 26841901)
AIDS Res Hum Retroviruses. 2018 Jan;34(1):3-8. (PMID: 28691499)
Sci Rep. 2017 Aug 21;7(1):8957. (PMID: 28827668)
Soc Sci Med. 2012 Nov;75(9):1555-61. (PMID: 22495513)
Am J Bioeth. 2016 Oct;16(10):25-7. (PMID: 27653396)
Nature. 2012 Jul 25;487(7408):482-5. (PMID: 22837004)
PLoS One. 2016 Jul 21;11(7):e0158767. (PMID: 27441648)
J Infect Dis. 2014 Sep 1;210(5):728-35. (PMID: 24620025)
PLoS Med. 2017 Nov 7;14(11):e1002417. (PMID: 29112956)
Lancet. 2008 Sep 6;372(9641):845-59. (PMID: 18687458)
N Engl J Med. 2015 Dec 3;373(23):2281-7. (PMID: 26624243)
Am J Bioeth. 2016 Oct;16(10):3-11. (PMID: 27653388)
Ann Intern Med. 2014 Sep 2;161(5):319-27. (PMID: 25047577)

P01 AI131385 United States AI NIAID NIH HHS; P30 AI036214 United States AI NIAID NIH HHS; R21 AI134295 United States AI NIAID NIH HHS; R21 HD094646 United States HD NICHD NIH HHS

Keywords: Eradication; HIV cure; Public health; Terminology

Date Created: 20180215 Date Completed: 20180622 Latest Revision: 20240315

20240315

PMC5812044

10.1186/s12889-018-5141-2

29439706